According to Phio Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$10.83 M. In 2022 the company made an earning of -$11.48 M an increase over its 2021 earnings that were of -$13.29 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$10.83 M | -5.7% |
2022 | -$11.48 M | -13.6% |
2021 | -$13.29 M | 51.09% |
2020 | -$8.8 M | -1.28% |
2019 | -$8.91 M | 21.03% |
2018 | -$7.36 M | -53.1% |
2017 | -$15.7 M | 74.49% |
2016 | -$9 M | -12.02% |
2015 | -$10.23 M | 16.17% |
2014 | -$8.8 M | -57.95% |
2013 | -$20.93 M | 62.45% |
2012 | -$12.89 M | 0.87% |
2011 | -$12.77 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 1,602.56% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | 75.02% | ๐บ๐ธ USA |